Genesis Healthcare, Inc. · OTC:GENNQ

Genesis Healthcare — Merrill Lynch (November 2004)

23 slides from Genesis Healthcare's conference presentation, Nov 30, 2004

  1. Slide 1: Genesis HealthCare Corporation

    Genesis HealthCare Corporation Merrill Lynch November 30, 2004

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain statements made in this presentation which are not historical facts may be “forward-looking” statements (as defined in the private securities litigation reform act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-lo

  3. Slide 3: Today's Agenda

    Today’s Agenda  Company Overview  Strategic Initiatives  Industry Issues  Financial Overview 22

  4. Slide 4: Genesis HealthCare Corporation

    Genesis HealthCare Corporation GHC is a leading provider of healthcare and support services to the post- acute elderly population in its core markets GHC operates 217 facilities, primarily SNFs  Operate over 26,000 beds of which 89% are SNFs  Facilities are operated along the east coast  Inpatien

  5. Slide 5: Company Highlights

    Company Highlights Valuable portfolio of high quality assets  Strong regional concentration  Significant facility ownership Stable reimbursement outlook  Medicare: 2.8% market basket adjustment effective October 1, 2004  Medicaid: Concentration in states with above average rate increases Substan

  6. Slide 6: Strategic Plan – Industry Environment

    Strategic Plan – Industry Environment  Limited investment in SNF asset development  Increasing acuity in the SNF setting  Changes in IRF, LTAC regulations  Penetration of managed care  Break down of regulatory barriers (i.e. 3 day hospital stay) 55

  7. Slide 7: Strategic Priorities

    Strategic Priorities  Operational Excellence  Achieve superior customer satisfaction  Meet market demand for clinical services  Secure top-quality staff in key operating positions  Improve operating efficiency  Expand Clinical Capabilities  Modernize Facilities 66

  8. Slide 8: Investment Priorities

    Investment Priorities  Expand clinical capabilities  Dialysis  Ventilator Care  Alzheimer’s  Facility modernization  Information systems 77

  9. Slide 9: Information System Priorities

    Information System Priorities Technology is the principal driver of operational excellence  Integrated operational, clinical and financial operating system  Integrated labor management system  Online purchasing system 88

  10. Slide 10: Value Creation

    Value Creation  Process Improvement Initiatives  Clinical quality  Labor management  Operating efficiency  Improve Financial Profile  Maximize Free Cash Flow  Debt reduction  Reduce cost of capital  Selective Investments  Information systems & infrastructure  Existing facilities  Fill-in

  11. Slide 11: Industry Issues

    Industry Issues

  12. Slide 12: Payor Continuum

    Payor Continuum Eldercare Line Private Hospital Medicare Pay & Medicaid External Care Other Coordinators • $354 Per • $203 Per • $163 Per Approx. 90% Diem Diem Diem of our patients • 15.7% of • 19.7% of • 64.6% of come from patients patients patients hospitals • ALOS • ALOS • ALOS 34 days 194 days 5

  13. Slide 13: Reimbursement Outlook

    Reimbursement Outlook  Stable Reimbursement Environment  2.8% market basket adjustment effective October 1, 2004  RUGs Refinement  Consultant recommendation to CMS in January 2005  Potential for “Super Skilled” category  Implication to providers  Provider Taxes  Recognized NH benefit in FY04

  14. Slide 14: Medicaid Rate Environment

    Medicaid Rate Environment  Medicaid revenues approximate 52% of inpatient revenues  Top 5 states represent 82% of Medicaid revenues Est. Annualized Contribution Date of Rate State to Medicaid Revenue Increase ’04 vs. ’03 PA $175.5 million 7/1 4.3% NJ $146.0 million 7/1; 4/1 5.3% MD $88.4 million 7

  15. Slide 15: Liability Insurance Program

    Liability Insurance Program Program Structure June ’04 – ‘05 • Fully insured, per occurrence & aggregate XL Insurance: $50 million per occurrence aggregate in excess of $50 million • Fully funded through captive insurance subsidiary • Limited exposure to high risk states • No prospective cash versus

  16. Slide 16: Financial Review

    Financial Review

  17. Slide 17: Financial Highlights

    Financial Highlights Fiscal Year Ended 9/30/04  Substantial Cash Flow  $148.4 million of operating cash flow for the year  $126.1 million of cash at end of quarter  Strong Fiscal Year Performance  10.3% net revenue growth over prior fiscal year  Operating margins grew from prior year  Strong

  18. Slide 18: Strong Cash Flow

    Strong Cash Flow • Q4 2004 operating cash flow of $48.2 million • $11 million reduction in accounts receivable • Fiscal 2004 operating cash flow of $148.4 million • Cash flow impacted by NOLs of approximately $100 million and tax deductible goodwill of approx. $96 million • Voluntarily repaid $77.7

  19. Slide 19: Financial Results

    Financial Results ($ in millions) Twelve Months Twelve Months Ended 9/30/04 Ended 9/30/03 Inpatient Services (1) Revenue $1,365.5 $1,216.6 EBITDA $172.6 120.6 EBITDA Margin 12.6% 9.9% Rehabilitation Services (1) (2) Revenue $197.1 $202.5 EBITDA $14.2 $31.0 EBITDA Margin 7.2% 15.3% Consolidated Reven

  20. Slide 20: Strong Working Capital Management

    Strong Working Capital Management Days Sales Outstanding vs. Receivables 185 48 180 46 $ in Millions 175 170 44 Days 165 42 160 40 155 150 38 145 36 Q1 2004 Q2 2004 Q3 2004 Q4 2004 Receivables Quarter DSO 19 19

  21. Slide 21: Capitalization – As of 9/30/04

    Capitalization – As of 9/30/04 ($ in millions) % of Cap Cash and Cash Equivalents (1) $126.1 - Senior Debt: Revolver (2) - 0.0% Term Loan B 134.1 13.8% Mortgages and Other Debt 44.0 4.5% Total Senior Debt 178.1 18.3% Senior Sub Notes due 2013 225.0 23.2% Total Debt 403.1 41.5% Book Equity 568.8 58.5

  22. Slide 22: Credit Statistics – As of 9/30/04

    Credit Statistics – As of 9/30/04 ($ in millions) (1) Net Debt / EBITDA 2.2x Debt/EBITDA 3.2x Total Debt/Book Capitalization 41.5% EBITDA/ Pro Forma Interest (2) 4.4x (EBITDA-Capex)/Interest(3) 3.3x Note: Fiscal year ended September 30, 2004 EBITDA from continuing operations only. Since GHC fully fu

  23. Slide 23: Company Highlights

    Company Highlights Valuable portfolio of high quality assets  Strong regional concentration  Significant facility ownership Stable reimbursement outlook  Medicare: 2.8% market basket adjustment effective October 1, 2004  Medicaid: Concentration in states with above average rate increases Substan

Genesis HealthCare — Merrill Lynch (November 2004) on 6ix